Unit
- Definition: Clinical trial registration is the process of uploading key details of a trial to a publicly accessible registry before the first participant is enrolled. This includes the trial's purpose, design, interventions, and outcome measures, creating a permanent record that reduces selective reporting and publication bias.
- Purpose: The primary goal is to increase transparency in clinical research by making trial information available to the public, researchers, and regulators. Registration helps prevent unnecessary duplication of studies, identifies gaps in evidence, and allows patients to find trials they may wish to join.
- Scope: Registration applies to interventional studies involving human participants, including randomized controlled trials, non-randomized studies, and early-phase trials. Observational studies may also be registered voluntarily to promote openness and facilitate meta-analyses.
- Core Data Elements: Registries require a standard set of information such as the trial identifier, sponsor name, funding source, study type, eligibility criteria, locations, and primary and secondary outcomes. This data set ensures consistency across different registries and enables cross-linking of results.
- Timing: Trials must be registered before enrollment of the first participant. Retrospective registration is often considered non-compliant and may raise concerns about selective outcome reporting. Some journals refuse to publish results from unregistered or retrospectively registered trials.
- Registries: Major registries include ClinicalTrials.gov (US), the EU Clinical Trials Register (EU), the WHO International Clinical Trials Registry Platform (ICTRP), and national registries like the Chinese Clinical Trial Register. These platforms share data to create a global research overview.
- Legal Mandates: Many countries now enforce registration by law. In the US, the FDA Amendments Act of 2007 requires registration of certain trials, while the EU Clinical Trials Regulation mandates registration for all trials conducted in the European Economic Area. Non-compliance can result in penalties and funding restrictions.
- Impact on Research Integrity: Registration deters practices such as data dredging, outcome switching, and publication of only positive results. By providing a public record of planned outcomes, it allows reviewers and readers to compare reported results with original objectives, enhancing trust in medical literature.
- Ethical Foundations: Registration aligns with the Declaration of Helsinki and other ethical guidelines that emphasize transparency and accountability in research involving human subjects. It protects participants by ensuring that trial information is openly available, and it upholds the ethical obligation to contribute to the collective knowledge base.
- Results Submission: Many registries require submission of summary results within one year of trial completion or within 30 days of product approval. This includes baseline characteristics, outcome data, and adverse events. Failure to submit results can lead to fines, loss of funding, or listing as noncompliant on the registry.
- Patient and Public Access: Registration empowers patients and healthcare providers to search for ongoing or completed trials relevant to specific conditions. Public access to trial protocols and results supports informed decision making and enables patients to identify opportunities for participation or to learn about new treatments.
- International Harmonization: The WHO ICTRP works to standardize registration requirements across countries, using a universal trial number (UTN) and common data set. This harmonization facilitates cross-border collaboration, reduces duplication, and allows global meta-analyses by ensuring that trials from different registries can be compared meaningfully.
Scope of Practice
Role: Clinical Research Coordinator
Within scope:
- Identifying the appropriate registry for each trial based on jurisdiction and funding source
- Collecting required data elements from the protocol and entering them accurately into the registry system
- Verifying that registration occurs before participant enrollment begins
- Updating registry entries when protocol amendments are approved
Outside scope:
- Deciding which outcomes to register without consulting the principal investigator
- Modifying registered data without documented approval from the sponsor or ethics committee
- Withdrawing a registration without formal closeout procedures
- Interpreting regulatory requirements without guidance from the institutional review board or legal team
Quick Revision
- Clinical trial registration creates a public record of trial details before enrollment begins.
- Core elements include trial identifier, sponsor, outcomes, and eligibility criteria.
- Legal mandates in the US and EU require registration; non-compliance can block publication.
- Research coordinators handle data entry and updates but do not interpret regulations alone.